| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2341553 | A | Cytotoxicity against african green monkey BSC40 cells | Chlorocebus aethiops | 1 | cell-based format | Scientific Literature | ||
| 2. | ALA2341554 | A | Cytotoxicity against dog MDCK cells | Canis lupus familiaris | 1 | cell-based format | Scientific Literature | ||
| 3. | ALA2341555 | A | Cytotoxicity against african green monkey Vero cells | Chlorocebus sabaeus | 1 | cell-based format | Scientific Literature | ||
| 4. | ALA2341556 | F | Antiviral activity against Chikungunya virus 181-25 infected in Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 to 6 days | Chikungunya virus | 1 | cell-based format | Scientific Literature | ||
| 5. | ALA2341557 | F | Antiviral activity against Vaccinia virus NYCBH infected in BSC-40 cells assessed as inhibition of virus-induced cytopathogenicity after 4 to 6 days | Vaccinia virus | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA2341558 | F | Antiviral activity against influenza H1N1 A/PR/8/34 infected in MDCK cells assessed as inhibition of virus-induced cytopathogenicity after 4 to 6 days | H1N1 subtype | 1 | cell-based format | Scientific Literature | ||
| 7. | ALA2341559 | F | Antiviral activity against Japanese encephalitis virus 14-14-2 infected in Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 to 6 days | Japanese encephalitis virus | 1 | organism-based format | Scientific Literature | ||
| 8. | ALA2341560 | F | Antiviral activity against Yellow fever virus 17D infected in Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 to 6 days | Yellow fever virus | 1 | cell-based format | Scientific Literature | ||
| 9. | ALA2341561 | F | Antiviral activity against Respiratory syncytial virus A2 infected in Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 to 6 days | Respiratory syncytial virus | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA2341562 | F | Antiviral activity against Dengue virus 3 strain H87 in Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 to 6 days | dengue virus type 3 | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA2341563 | F | Antiviral activity against Dengue virus 4 strain H241 in Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 to 6 days | dengue virus type 4 | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA2341564 | F | Antiviral activity against Dengue virus 2 strain New Guinea C in Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 to 6 days | dengue virus type 2 | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA2341565 | F | Antiviral activity against Dengue virus 1 strain TH-S-MAN in Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 to 6 days | dengue virus type 1 | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA2341566 | F | Antiviral activity against Herpes simplex virus-1 HF infected in Vero cells assessed as inhibition of virus-induced cytopathogenicity after 4 to 6 days | Human alphaherpesvirus 1 | 1 | organism-based format | Scientific Literature | ||
| 15. | ALA2341567 | A | Cytotoxicity against human PBMC measured after 7 days by MTS assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 16. | ALA2341568 | F | Antiviral activity against HIV-1 group M subtype B MDR769 infected in human PBMC assessed as inhibition of virus replication measured after 7 days by MTS assay | HIV-1 group M | 1 | assay format | Scientific Literature | ||
| 17. | ALA2341569 | F | Antiviral activity against HIV-1 group M subtype B NL4-3 infected in human PBMC assessed as inhibition of virus replication measured after 7 days by MTS assay | HIV-1 group M | 1 | assay format | Scientific Literature | ||
| 18. | ALA2341570 | F | Antiviral activity against HIV-1 group M subtype B Bal infected in human PBMC assessed as inhibition of virus replication measured after 7 days by MTS assay | HIV-1 group M | 1 | assay format | Scientific Literature | ||
| 19. | ALA2341571 | F | Antiviral activity against HIV-1 group M subtype G G3 infected in human PBMC assessed as inhibition of virus replication measured after 7 days by MTS assay | HIV-1 group M | 1 | assay format | Scientific Literature | ||
| 20. | ALA2341572 | F | Antiviral activity against HIV-1 group M subtype E CMU08 infected in human PBMC assessed as inhibition of virus replication measured after 7 days by MTS assay | HIV-1 group M | 1 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!